Publicacións en colaboración con investigadores/as de Hospital Universitario de Canarias (18)

2024

  1. Combined use of QRISK3 and SCORE2 increases identification of ankylosing spondylitis patients at high cardiovascular risk: Results from the CARMA Project cohort after 7.5 years of follow-up

    Seminars in Arthritis and Rheumatism, Vol. 66

  2. Use of risk chart algorithms for the identification of psoriatic arthritis patients at high risk for cardiovascular disease: findings derived from the project CARMA cohort after a 7.5-year follow-up period

    RMD open, Vol. 10, Núm. 2

2020

  1. Association of apolipoprotein B/apolipoprotein A1 ratio and cardiovascular events in rheumatoid arthritis: results of the CARMA study

    Clinical and experimental rheumatology, Vol. 38, Núm. 4, pp. 662-669

2019

  1. Identification of a 3′-Untranslated Genetic Variant of RARB Associated With Carotid Intima-Media Thickness in Rheumatoid Arthritis: A Genome-Wide Association Study

    Arthritis and Rheumatology, Vol. 71, Núm. 3, pp. 351-360

2017

  1. Influence of coronary artery disease and subclinical atherosclerosis related polymorphisms on the risk of atherosclerosis in rheumatoid arthritis

    Scientific Reports, Vol. 7

  2. Lipoprotein(a) concentrations in rheumatoid arthritis on biologic therapy: Results from the CARdiovascular in rheuMAtology study project

    Journal of Clinical Lipidology, Vol. 11, Núm. 3, pp. 749-756.e3

2016

  1. Cardiovascular risk assessment in patients with rheumatoid arthritis: The relevance of clinical, genetic and serological markers

    Autoimmunity Reviews, Vol. 15, Núm. 11, pp. 1013-1030

  2. Influence of elevated-CRP level-related polymorphisms in non-rheumatic Caucasians on the risk of subclinical atherosclerosis and cardiovascular disease in rheumatoid arthritis

    Scientific Reports, Vol. 6

2015

  1. Cardiovascular morbidity and associated risk factors in Spanish patients with chronic inflammatory rheumatic diseases attending rheumatology clinics: Baseline data of the CARMA Project

    Seminars in Arthritis and Rheumatism, Vol. 44, Núm. 6, pp. 618-626

  2. Cardiovascular risk assessment in rheumatoid arthritis: What goals should be achieved?

    Seminars in Arthritis and Rheumatism

  3. Erratum to "Cardiovascular morbidity and associated risk factors in Spanish patients with chronic inflammatory rheumatic diseases attending rheumatology clinics: Baseline data of the CARMA Project" [Semin Arthritis Rheum 44 (2015) 618-626]

    Seminars in Arthritis and Rheumatism

  4. Osteoprotegerin concentrations relate independently to established cardiovascular disease in rheumatoid arthritis

    Journal of Rheumatology, Vol. 42, Núm. 1, pp. 39-45

  5. Protective role of the interleukin 33 rs3939286 gene polymorphism in the development of subclinical atherosclerosis in rheumatoid arthritis patients

    PLoS ONE, Vol. 10, Núm. 11

  6. TNF-related apoptosis-inducing ligand and cardiovascular disease in rheumatoid arthritis

    Clinical and Experimental Rheumatology, Vol. 33, Núm. 4, pp. 491-497

  7. Vitamin D deficiency in chronic inflammatory rheumatic diseases: Results of the cardiovascular in rheumatology [CARMA] study

    Arthritis Research and Therapy, Vol. 17, Núm. 1

2014

  1. Recommendations for the management of cardiovascular risk in patients with rheumatoid arthritis: Scientific evidence and expert opinion

    Seminars in Arthritis and Rheumatism, Vol. 44, Núm. 1, pp. 1-8

2013

  1. Metabolic syndrome in rheumatoid arthritis

    Mediators of Inflammation, Vol. 2013

2011

  1. Resistencia insulínica y artritis reumatoide

    Reumatologia Clinica